After Hours Summary: PANW +10.4%, RIOT +3% higher on earnings; CARA jumps +24% on FDA approval; TBPH drops -24.9% on clinical data for IzencitinibAfter Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: PANW +10.4%, RIOT +3%
Companies trading higher in after hours in reaction to news: CARA +24% (FDA approval of KORSUVA), BXC +6.6% (authorizes new $25 mln share repurchase program; also announces termination of ATM offering), CWH +5.5% (increases dividend), NRZ +3.9% (increases dividend), NOV +1.8% (announces supply contract with COSCO Shipping), MOS +0.8% (authorizes new $1 bln share repurchase program), EXR +0.3% (increases dividend), WMB +0.2% (CFO to retire)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: None
Companies trading lower in after hours in reaction to news: TBPH -24.9% (reports its study of Izencitinib did not meet its primary endpoint), SO -0.2% (CFO to retire; names new CFO)
- Reports Q4 (Jul) earnings of $1.60 per share, excluding non-recurring items, $0.16 better than the S&P Capital IQ Consensus of $1.44; revenues rose 28.3% year/year to $1.22 bln vs the $1.17 bln S&P Capital IQ Consensus.
- Q4 billings grew 34% yr/yr to $1.90 bln vs $1.695-1.715 bln prior guidance.
- Co issues mixed guidance for Q1 (Oct), sees EPS of $1.55-1.58, excluding non-recurring items, vs. $1.60 S&P Capital IQ Consensus; sees Q1 revs of $1.19-1.21 bln vs. $1.15 bln S&P Capital IQ Consensus. Co guides to Q1 billings of $1.29-1.31 bln.
- Co issues upside guidance for FY22, sees EPS of $7.15-7.25, excluding non-recurring items, vs. $7.09 S&P Capital IQ Consensus; sees FY22 revs of $5.275-5.325 bln vs. $5.02 bln S&P Capital IQ Consensus.
Closing Stock Market SummaryThe stock market had a strong start to the week, as investors remained steadfast in buying the dip amid some encouraging Covid news. The S&P 500 (+0.9%) and Nasdaq Composite (+1.6%) set intraday record highs, with the Nasdaq also closing at a record high.
The Dow Jones Industrial Average (+0.6%) trailed its large-cap peers with a 0.6% gain while the Russell 2000 (+1.9%) and iShares Micro-Cap ETF (IWC 143.33, +3.87, +2.8%) outperformed after underperforming last week.
Briefly, the FDA fully approved the Pfizer (PFE 49.93, +1.21, +2.5%)-BioNTech (BNTX 382.10, +33.42, +9.6%) vaccine for people 16 years and older, which provided some hope that vaccination rates will increase. In addition, the IHME vaccine model suggested that coronavirus cases could be peaking in the U.S.
The gains were relatively broad-based, as advancing issues outpaced declining issues by a 2:1 margin at the NYSE and a 3:1 margin at the Nasdaq. Seven of the 11 S&P 500 sectors closed higher, including the energy sector (+3.8%), which rose 4% as oil prices ($65.60, +3.35, +5.4%) rebounded 5%.
The heavily-weighted information technology sector (+1.3%) advanced 1.3%, while the defensive-oriented utilities (-1.3%), real estate (-0.4%), consumer staples (-0.4%), and health care (-0.02%) sectors were excluded from the advance amid some slippage into the close.
Other supportive factors included preliminary manufacturing and services PMIs for August out of the eurozone and U.S. that were expansionary (although they did decelerate from July), news that Treasury Secretary Yellen will back Fed Chair Powell for a second term, and a Barron's cover story that described the mega-cap technology stocks as "unstoppable."
Elsewhere, Treasury yields were subdued despite the bullish price action in the major indices, reportedly because of the deceleration in the IHS data, reduced trading volume, and a wait-and-see mindset for Fed Chair Powell's speech on Friday. Mr. Powell will speak during the annual Jackson Hole Economic Symposium.
The 10-yr yield decreased one basis point to 1.26% while the 2-yr yield increased one basis point to 0.23%. The U.S. Dollar Index decreased 0.5% to 92.99.
Reviewing Monday's economic data:
- Existing home sales increased 2.0% m/m in July to a seasonally adjusted annual rate of 5.99 million (consensus 5.85 million) from an upwardly revised 5.87 million (from 5.86 million) in June. Total sales in July were up 1.5% from a year ago.
- The key takeaway from the report is that the supply of existing homes for sale at more affordable price points remains extremely limited. That is driving up the pace of price increases well beyond the pace of income growth, which is creating affordability pressures for prospective buyers, particularly first-time buyers, and leading much of the sales growth to occur in higher-end markets.
- The preliminary IHS Markit Manufacturing PMI decreased to 61.2 in August from 63.4 in July. The preliminary IHS Markit Services PMI decreased to 55.2 in August from 59.9 in July.
Looking ahead, investors will receive New Home Sales for July on Tuesday.
- S&P 500 +19.3% YTD
- Nasdaq Composite +15.9% YTD
- Dow Jones Industrial Average +15.5% YTD
- Russell 2000 +11.8% YTD
There is an old adage that says never bet against the US Consumer's willingness to spend. In fact, it was one of the primary reasons we led the charge on recommending consumer cyclicals back in April 2020 at the depths of the COVID recession. Indeed, with Congress expeditiously providing record amounts of fiscal stimulus last year, the table was set for a major consumer stand against the downturn. Fast forward 16 months and it's fair to say the US consumer has not disappointed. But, after a year of remarkable resilience from the US consumer, it begs the question: "Is it sustainable?" While there is little doubt about the US consumers' willingness to spend, the other key variable to consider is their ability to spend.
- first, there wasn't much of a recession at all when looking at Real Personal Consumption over the last 18 months.
- second, It's the same story when looking at nominal retail sales which tells us we should expect a reversion to trend now that the stimulus is behind us.
- First, the headline plunged to new cycle lows, below the levels witnessed during the worst of the lock downs and when it really did feel like a recession.
- Second, it's not unprecedented for consumer sentiment to fall to new lows post a recession. In fact, we saw the same thing in the prior two recessions (red circles on Exhibit 5). In the 2001- 2009 and 1982-89 expansions, consumer sentiment never really recovered and both of those cycle proved to be less exciting for consumer oriented stocks and the economy. Contrast that with the 1990-2000 and 2009-2020 expansions where the consumer sentiment continued to climb and fueled the longest and strongest recoveries on record.






